Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Community study of nitrendipine + atenolol combination tablets for primary hypertension
ChiCTR-ONC-11001645Phase 4Completed
- Sponsor
- Beijing Hypertension League Institute
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nitrendipine and atenolol in essential hypertension, sponsored by Beijing Hypertension League Institute. Primary endpoint: Blood pressure. Started Oct 2011; status: completed.
02
Drugs
nitrendipineatenolol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR-ONC-11001645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-11001645.